摘要 |
<p>Novel pharmaceutical use of 5-[4-(6-methoxy-1-methyl-1H-benzoimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione being a condensed heterocyclic compound, or a salt thereof. This 5-[4-(6-methoxy-1-methyl-1H-benzoimidazol-2-ylmethoxy)benzyl]thiazolidine-2,4-dione or salt thereof can exert excellent curing accelerating effect with respect to dry eye models and is useful as a therapeutic agent for keratoconjunctive disorders, such as dry eye, corneal ulcer, keratitis, conjunctivitis, superficial punctate corneal disorder, corneal epithelial loss, conjunctival epithelial loss, keratoconjunctivitis sicca, superior limbic keratoconjunctivitis and filamentary keratitis.</p> |
申请人 |
SANTEN PHARMACEUTICAL CO., LTD.;NAKAMURA, MASATSUGU;HIRAI, SHIN-ICHIRO |
发明人 |
NAKAMURA, MASATSUGU;HIRAI, SHIN-ICHIRO |